A bipartisan bill to add post-traumatic stress disorder (PTSD) as a qualifying condition for New York’s medical marijuana program was signed into law by Gov. Andrew Cuomo during Veterans Day weekend. The Senate passed S 5629 in June (50-13), and the Assembly version, A 7006, received overwhelming approval in May (131-8). New York is the 28th state to allow medical marijuana to be used to treat PTSD.
“Gov. Cuomo should be applauded for helping thousands of New York veterans find relief with medical…
On Tuesday, the New York Senate took an important step toward improving the state’s medical marijuana program by passing S 5629, which would add post-traumatic stress disorder (PTSD) as a qualifying condition. The Assembly had already overwhelmingly passed an identical bill, A 7006. The bills now head to Gov. Andrew Cuomo’s desk.
MPP's Kate Bell said the following in a press release:
“State lawmakers are standing up for thousands of New Yorkers who are suffering from PTSD and might benefit from medical…
New York is one of the only states that does not list post-traumatic stress disorder (PTSD) as a qualifying condition for its medical marijuana program. The state got one step closer to remedying that today, when the Assembly voted overwhelmingly (101-6) to approve A 7006. The bill now heads to the Senate.
Twenty-four of the 29 states with medical marijuana programs allow patients with PTSD to qualify. Two of those that do not (Colorado and Alaska) allow all adults 21 and up to legally purchase and…
New York recently expanded its medical marijuana program by adding chronic pain, but there is an important group of patients who are still left out — those who suffer from post-traumatic stress disorder (PTSD). Twenty-four of the 29 states with medical marijuana programs allow patients with PTSD to qualify, but New York still does not. A 7006 and S 5629 would change that; please ask your legislators to support these bills.
Last week, the Assembly Health Committee voted unanimously to approve A 7006,…
